Dr. Ajlan Al Zaki

Dr. Ajlan Al Zaki is a Staff Physician in the Hematology & Blood Cancer Department at Cleveland Clinic Abu Dhabi's Cancer Institute. An Emirati physician-scientist, he previously served as Director of Hematology Oncology & Cellular Therapy at Burjeel Hospital in Abu Dhabi. His career reflects a strong commitment to both clinical excellence and translational research, bridging laboratory discovery with patient care.

Dr. Al Zaki trained at leading international institutions including MD Anderson Cancer Center, where he gained extensive experience in clinical trial design and researching CAR T-cell therapy—a cutting-edge approach to treating blood cancers. He specializes in treating leukemia, lymphoma, and multiple myeloma, and has particular expertise in emerging therapies such as CAR T-cell treatment and bispecific antibodies. He has authored 32 peer-reviewed publications, holds five patents, and contributed book chapters in hematologic oncology.

Driven by his research background and clinical training, Dr. Al Zaki is focused on expanding access to innovative cancer therapies in the Middle East and beyond. He is a good fit for patients seeking specialist care in blood cancers, particularly those interested in participation in clinical trials or access to newer immunotherapies.